Drugmaker Laurus Labs has reported ₹272.85 crore consolidated net profit for the quarter ended December, which is nearly a four fold increase from the ₹73.47 crore posted in the corresponding period of previous fiscal.
Revenue from operations increased 76% to ₹1,288.42 (₹729.59 crore), while total income at ₹1,295.35 crore (₹731.51) was 77% higher.
Founder and CEO Satyanarayana Chava said all the divisions contributed to the growth in revenue. The generic API division recorded a growth of over 100% for the quarter. It was led by higher growth in ARV API business and higher volume of 1st line products.
In the Generic FDF (fixed dosage formulations) business segment, the growth in the quarter was led by higher sales from tender business in LMIC (low and middle income countries). The company said the order book for coming quarters is strong. During the quarter, marketing of in-licensed products in the US was commenced.
A release from Laurus Labs said revenue from the Synthesis and Ingredients segment increased 63% year on year during the quarter.
Interim Dividend
The company has declared second interim dividend of 40 Paise (20%) per equity share of ₹2 each for the fiscal. February 9 will be record date for determining the eligibility of the shareholders and the dividend will be paid on or after February 18.
EOM
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
